Pfizer Inc

Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says

hamiddebared@gmail.com1 day ago04 mins

The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of weight loss drugs, preferring instead to focus on areas where it can build a “unique position.” Speaking to CNBC, Vas Narasimhan said that the company was researching treatments that deal with the secondary effects of…

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

hamiddebared@gmail.com5 days ago06 mins

Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday. Patients with the condition, called cancer cachexia, who took Pfizer’s treatment saw improvements in body weight, muscle mass, quality of life and physical function, according to…

Moderna shares plunge on plans to cut .1 billion in costs, launch 10 new products by 2027

Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027

hamiddebared@gmail.com1 week ago011 mins

Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business. …

FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout

hamiddebared@gmail.com3 weeks ago04 mins

A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | Reuters The Food and Drug Administration authorized Novavax‘s updated protein-based Covid vaccine for emergency use in people ages 12 and up on Friday, paving the way for the shot to compete with Pfizer and Moderna‘s jabs…